emerg
infecti
diseas
caus
global
effort
develop
fast
accur
detect
techniqu
rapidli
mutat
natur
virus
present
major
difficulti
highlight
need
specif
detect
genet
divers
strain
one
infecti
agent
sarsassoci
coronaviru
sarscov
emerg
studi
aim
develop
realtim
rtpcr
detect
assay
specif
sarscov
take
account
intrins
polymorph
natur
due
genet
drift
recombin
possibl
continu
multipl
introduct
genet
nonident
strain
human
popul
use
mismatchtoler
molecular
beacon
design
specif
detect
sarscov
e
n
gene
appli
simpl
reproduc
duplex
multiplex
realtim
pcr
assay
postmortem
sampl
construct
rna
control
demonstr
high
target
detect
abil
specif
assay
readili
adapt
detect
emerg
rapidli
mutat
pathogen
emerg
virus
high
rate
genet
drift
caus
setback
global
scientif
effort
develop
fast
accur
diagnost
detect
method
novel
viru
sarsassoci
coronaviru
sarscov
spread
throughout
world
quickli
characteris
link
sever
acut
respiratori
syndrom
sar
human
coronavirus
confin
mainli
upper
respiratori
tract
caus
simpl
ill
wherea
anim
associ
sever
diseas
still
ongo
possibl
sarscov
reemerg
sinc
evid
suggest
aros
anim
coronaviru
poor
clinic
definit
lack
known
prevent
method
treatment
mean
earli
diagnosi
crucial
huge
effort
develop
diagnost
nevertheless
molecular
detect
test
suffer
speed
sensit
limit
standardis
accur
prompt
detect
viru
therefor
prioriti
current
molecular
assay
fail
consid
intrins
polymorph
natur
coronavirus
seen
pathogen
sarscov
urbani
strain
possibl
continu
introduct
genet
nonident
strain
human
popul
studi
aim
develop
realtim
rtpcr
assay
use
mismatchtoler
molecular
beacon
detect
sarscov
distinguish
pathogen
nonpathogen
strain
assay
incorpor
four
beacon
target
e
n
gene
addit
intern
posit
control
ipc
valid
use
clinic
sampl
primer
molecular
beacon
design
de
novo
studi
tabl
small
region
nucleotid
long
sarscov
e
n
gene
target
detect
fig
oligonucleotid
design
base
multipl
align
sequenc
gene
avail
genbank
databas
http
wwwncbinlm
nihgovgenbank
thermodynam
compat
care
choic
beacon
primer
use
integr
dna
technolog
http
euidtdnacom
dimeris
tool
ensur
avoid
potenti
hazard
primerprim
molecular
beaconprim
dimeris
thermodynam
compat
beacon
applic
fiveamplicon
multiplex
assay
molecular
beacon
target
oligonucleotid
primer
synthesis
mwgbiotech
ag
ltd
ebersberg
germani
facilit
format
stem
structur
end
molecular
beacon
design
high
gc
content
complementari
beacon
label
dabcyl
dimethylaminophenylazo
benzoic
acid
end
tet
carbofluorescein
end
except
mbipc
ipc
beacon
label
fam
fluorescein
form
loop
element
beacon
design
contain
probe
sequenc
complementari
part
gene
fragment
amplifi
beacon
design
form
long
stabl
hybrid
give
abil
mismatchtoler
mean
beacon
still
detect
target
amplicon
despit
polymorph
substitut
aris
consequ
genet
drift
viru
viral
recombin
gc
content
beacon
kept
high
ensur
pcr
cycl
condit
molecular
beacon
would
remain
close
conform
absenc
target
order
identifi
best
target
sequenc
within
viral
gene
would
discrimin
sarsurbani
strain
nonpathogen
human
anim
coronaviru
strain
multipl
sequenc
align
avail
coronaviru
gene
sequenc
deposit
genbank
carri
fig
dna
sequenc
sarscov
gene
sarsurbani
genbank
access
number
compar
refer
virus
repres
speci
three
known
group
coronavirus
refer
sequenc
group
includ
human
coronaviru
porcin
epidem
diarrhea
viru
pedv
transmiss
gastroenter
viru
tgev
canin
coronaviru
ccov
felin
coronaviru
fcov
porcin
respiratori
coronaviru
prcov
group
bovin
coronaviru
bcov
murin
hepat
viru
mhv
human
coronaviru
porcin
hemagglutin
encephalomyel
viru
hev
rat
coronaviru
rtcov
refer
viru
group
infecti
bronchiti
viru
ibv
sequenc
align
perform
clustalw
identifi
genom
region
highest
genet
distanc
sarscov
coronaviru
strain
special
emphasi
probetarget
sequenc
encompass
gap
delet
sarscov
genom
like
probe
sequenc
primer
select
also
base
abil
amplif
sarscov
target
would
form
primertarget
probetarget
hybrid
theoret
melt
temperatur
would
maxim
abil
primer
bind
target
even
nucleotid
substitut
present
achiev
mismatch
toler
final
primer
sequenc
select
enabl
amplicon
form
approxim
length
nucleotid
intern
posit
control
synthet
oligonucleotid
design
amplifi
forward
gene
revers
e
gene
primer
tabl
use
intern
posit
control
ipc
amplif
thermodynam
characterist
molecular
beacon
assess
melt
curv
analys
perform
prism
spectrofluorometr
thermal
cycler
appli
biosystem
foster
citi
ca
usa
valid
use
ht
fast
realtim
pcr
system
appli
biosystem
differ
concentr
beacon
use
find
one
fluoresc
neither
low
satur
reaction
consist
platinum
pcr
supermix
invitrogen
beacon
variou
concentr
without
pmol
singlestrand
complementari
target
cycl
paramet
follow
min
follow
cycl
data
collect
second
step
start
decreas
per
cycl
fluoresc
measur
nm
record
cycl
rna
transcript
correspond
target
prepar
vitro
transcript
use
megascript
transcript
kit
ambion
houston
tx
accord
manufactur
instruct
dna
templat
gener
pcr
use
forward
primer
tabl
sampl
includ
studi
collect
patient
met
cdcwho
case
definit
probabl
sar
toronto
canada
fifti
postmortem
tissu
sampl
tabl
collect
patient
die
probabl
sar
twentyon
postmortem
two
premortem
tissu
sampl
eight
individu
die
caus
sar
outbreak
includ
control
sampl
collect
time
autopsi
snapfrozen
ethanol
dri
ice
store
sampl
code
process
independ
studi
approv
research
ethic
board
mount
sinai
hospit
univers
health
network
toronto
chief
coron
offic
ontario
canada
rtpcr
prepar
mg
sampl
thaw
homogen
rlt
lysi
buffer
qiagen
use
dispos
tissu
grinder
kendal
precis
tm
mansfield
usa
homogen
pass
qiashredd
column
qiagen
prior
rna
isol
use
rneasi
mini
kit
qiagen
realtim
rtpcr
carri
lightcycl
realtim
pcr
platform
roch
diagnost
laval
canada
use
taq
polymeras
pcr
kit
invitrogen
reaction
contain
templat
cdna
pmol
beacon
mbipc
primer
pmol
mgcl
pcr
buffer
cycl
condit
cycl
data
collect
nontempl
control
also
run
multiplex
protocol
cycl
condit
reagent
appli
beacon
primer
tabl
four
sarscov
gene
pmol
ad
reaction
similar
analysi
perform
synthet
rna
standard
revers
transcript
carri
describ
duplex
realtim
rtpcr
carri
use
prism
spectrofluorometr
thermal
cycler
appli
biosystem
confirm
ht
fast
realtim
pcr
system
appli
biosystem
duplex
pcr
reaction
contain
cdna
quantit
supermixudg
invitrogen
pmol
mbipc
pmol
molecular
beacon
tabl
pmol
target
ipc
primer
tabl
initi
denatur
carri
min
follow
cycl
data
collect
step
evalu
specif
target
detect
abil
assay
confid
interv
calcul
use
wilson
score
interv
normalis
fluoresc
signal
beacon
beacontarget
hybrid
plot
temperatur
give
thermal
denatur
profil
fig
determin
optim
hybridis
temperatur
beacon
target
beacon
alon
exhibit
melt
temperatur
temperatur
rang
probetarget
hybrid
elicit
significantli
stronger
fluoresc
probe
alon
allow
clear
detect
temperatur
chosen
optim
realtim
pcr
reaction
optim
concentr
beacon
found
pmolll
assay
test
synthet
rna
standard
clinic
sampl
tabl
sampl
investig
duplic
duplex
multiplex
assay
detect
ipc
e
n
gene
posit
result
c
valu
lung
tissu
intestin
tissu
specimen
sarscovinfect
case
found
posit
four
target
indic
detect
abil
ci
specif
also
ci
sinc
control
specimen
neg
c
nontempl
control
includ
assay
exhibit
undetect
amplif
c
detect
ipc
sarscovspecif
gene
clear
sarscovinfect
sampl
wherea
ipc
amplif
detect
control
result
show
realtim
rtpcr
accur
detect
sarscov
rna
accur
specif
enough
distinguish
sarscovinfect
sampl
control
sampl
assay
give
result
three
differ
pcr
platform
use
lightcycl
technolog
describ
studi
part
us
patent
issu
may
heart
small
intestin
heart
small
intestin
skelet
muscl
larg
intestin
heart
futur
reemerg
sarscov
possibl
sinc
virus
difficult
erad
abl
surviv
intermedi
host
fast
accur
detect
assay
routin
diagnost
test
may
crucial
therapi
appli
effici
effect
furthermor
assay
may
adapt
mutat
infecti
agent
also
pose
public
health
hazard
despit
coronaviru
morpholog
sarscov
strain
urbani
distant
relationship
known
coronavirus
phylogenet
analysi
reveal
region
low
similar
sarscov
strain
coronavirus
genet
distant
region
use
design
primer
molecular
beacon
figur
lack
signific
phylogenet
relationship
sarscov
coronavirus
e
n
protein
report
previous
studi
also
demonstr
recombin
n
protein
sarscov
lineag
fact
transcrib
larg
quantiti
reason
choos
n
gene
target
exist
sar
detect
methodolog
fail
consid
polymorph
natur
coronavirus
account
possibl
introduct
genet
nonident
strain
human
popul
present
assay
tackl
first
use
multipl
genet
sequenc
target
reason
use
four
differ
molecular
beacon
target
differ
gene
minimis
likelihood
detect
sarscov
due
continu
evolutionari
chang
viru
also
simultan
detect
four
target
multiplex
singlefluorophor
detect
detect
sensit
enhanc
compar
detect
one
target
sarscov
viral
load
extrem
low
diseas
onset
rais
major
challeng
earli
detect
secondli
mismatchtoler
molecular
beacon
design
achiev
compromis
specif
mismatch
toler
tradit
target
chosen
perfectli
complementari
probe
make
bind
extrem
specif
mismatchtoler
beacon
form
longer
probetarget
hybrid
allow
duplex
contain
mismatch
basepair
thu
beacon
design
bind
gene
region
select
pathogen
strain
time
could
toler
unpredict
base
substitut
assay
exhibit
target
detect
abil
specif
detect
limit
assay
also
investig
construct
standard
curv
use
vitro
rna
transcript
linear
rang
target
concentr
lower
limit
detect
copi
per
reaction
data
shown
sarscovinfect
clinic
sampl
posit
control
sampl
neg
tabl
low
c
valu
observ
lung
sampl
sarscov
viral
load
report
highest
amongst
human
organ
furthermor
result
support
report
viral
dissemin
lobe
lung
multiorgan
viral
dissemin
potenti
fals
neg
result
avoid
includ
intern
posit
control
first
report
realtim
rtpcr
sarscov
detect
assay
molecular
beacon
toler
mutat
attribut
genet
drift
recombin
distinguish
sarscov
nonpathogen
coronaviru
strain
includ
intern
posit
control
assay
provid
fast
simpl
way
detect
sarscov
diagnost
test
importantli
provid
templat
fast
molecular
detect
assay
emerg
mutat
pathogen
